DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 1Pharmathen SA
03 4Accord healthcare
04 1Activo Health
05 1Akorn Pharmaceuticals
06 1Aurobindo Pharma Limited
07 1Austell Laboratories
08 2Avet Pharmaceuticals
09 2Avyxa
10 1Baxter Healthcare Corporation
11 1Biem Ilac San. ve Tic. A.S
12 1Chartwell Pharmaceuticals llc
13 1Cipla
14 2Dr Reddy's Laboratories (Australia) Pty Ltd
15 2Eurolab
16 4Farbe Firma
17 1Farmatek
18 1Fresenius Kabi AB Brunna
19 3Fresenius Kabi USA
20 1Fresenius SE & Co. KGaA
21 2Hangzhou Jiuyuan Gene Engineering
22 15Helsinn Advanced Synthesis
23 1Hetero Drugs
24 1Hikma Pharmaceuticals
25 2Hospira, Inc.
26 1Jiangsu Hengrui Medicine
27 2Juniper Biologics
28 2Knight Therapeutics
29 1Labatec Pharm
30 4Medius AG
31 2Medsurge Healthcare
32 1Meitheal Pharmaceuticals
33 1Novast Laboratories
34 1ORIFARM GROUP AS
35 1Pharmada Pharmaceuticals
36 1Polifarma
37 2Qilu Pharmaceutical
38 2Sagent Pharmaceuticals
39 3Samyang Biopharmaceuticals
40 2Sandoz B2B
41 1Tecnimede
42 4Teva Pharmaceutical Industries
43 2TherDose Pharma
44 1Viatris
45 1Yangtze River Pharmaceutical Group
01 1CAPSULE
02 2CAPSULE;ORAL
03 1Caps
04 1Capsule
05 1Capsule, hard
06 2Capsule, soft
07 1Hard Capsule
08 7INJ
09 1INJECTABLE;INJECTION
10 25INJECTABLE;INTRAVENOUS
11 1IV Injection Solution
12 1Inf Conc
13 5Inj L?s
14 1Injectable Solution
15 12Injection
16 3Injection fluid, resolution
17 1Kaps
18 2Kapsel, hard
19 3Liquid Injection
20 1Netupitant+Palonosetron 0,5+300Mg 1 Combined Oral Use
21 1POWDER;INTRAVENOUS
22 1Palonosetron 250Mcg 5Ml 1 Units Parenteral Use
23 1SOFT CAPSULE
24 1SOLUTION
25 1SOLUTION FOR INJECTION
26 5SOLUTION;INTRAVENOUS
27 1Solution for I.V. Injection
28 1Solution for IV Injection
29 1Solution for Injection
30 6Blank
01 14DISCN
02 6Generic
03 2Lead Market Dossiers- Filed
04 2Originator
05 2Prescription
06 19RX
07 1USA
08 45Blank
01 4AKYNZEO
02 4ALOXI
03 6Akynzeo
04 1Akynzeo IV
05 10Aloxi
06 1Hetnoset
07 1Kemoprev IV
08 1Onicit
09 2PALIBOUT
10 3PALONOSETRON
11 1PALONOSETRON 0.05mg/ml FRESENIUS
12 1PALONOSETRON 0.25 TEVA
13 26PALONOSETRON HYDROCHLORIDE
14 2PALONOSETRON Medsurge
15 2POSFREA
16 1Palcita
17 2Palonosetron Accord
18 2Palonosetron Dr.Reddy's
19 1Palonosetron Fresenius Kabi
20 1Palonosetron Labatec
21 1Palonosetron Sandoz
22 1Palonosetron-Teva
23 1Paloxitron
24 1Palton
25 1Votron
26 14Blank
01 6Australia
02 2Canada
03 4China
04 1Greece
05 8India
06 2Italy
07 8Norway
08 1Portugal
09 8South Africa
10 3South Korea
11 2Sweden
12 8Switzerland
13 4Turkey
14 34USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : DISCN
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 300; 0.5
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.075MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.25MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-03-15
Application Number : 204615
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 0.25MG(BASE)/5ML
Packaging :
Approval Date :
Application Number : 204731
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-11-06
Application Number : 204702
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-11-12
Application Number : 206916
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 206396
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 206801
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 206802
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-07-25
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-29
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-08-22
Application Number : 22233
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
NETUPITANT; PALONOSETRON HYDROCHLORIDE
Brand Name : AKYNZEO
Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG;EQ 0.5MG BASE
Packaging :
Approval Date : 2014-10-10
Application Number : 205718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 207005
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 207005
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 205648
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 205648
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 204289
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 205870
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2015-10-13
Application Number : 202521
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 206416
Regulatory Info : RX
Registration Country : USA
